Report cover image

Diabetic Foot Ulcers Market Report and Forecast 2024-2032

Publisher Expert Market Research
Published Feb 09, 2024
Length 140 Pages
SKU # EMAR18558271

Description

Diabetic Foot Ulcers Market Report and Forecast 2024-2032


Diabetic Foot Ulcers Market Report and Forecast 2024-2032

Diabetic Foot Ulcers Market Outlook

The diabetic foot ulcers market size was valued at USD 6.32 billion in 2023, driven by increasing prevalence of diabetes. The market size is anticipated to grow at a CAGR of 5.85% during the forecast period of 2024-2032 to achieve a value of USD 10.5 billion by 2032.

Diabetic Foot Ulcers: Introduction

Diabetic foot ulcers are open sores or wounds that occur in approximately 15% of patients with diabetes and commonly develop on the bottom of the foot. They are a major complication of diabetes, resulting from a combination of factors, including poor circulation, neuropathy (nerve damage), foot deformities, and pressure or friction. These ulcers can become serious if not treated promptly, as they may lead to infections and, in severe cases, amputation.

Key Trends in the Diabetic Foot Ulcers Market

Globally, the increasing prevalence of diabetes due to sedentary lifestyles, obesity, and aging populations is leading to a higher incidence of diabetic foot ulcers. This trend is prompting a growing demand for effective treatment options and is driving research and development in this field.

There is a significant trend towards the adoption of advanced wound care products, including biologics, skin substitutes, and advanced dressings. These technologies are designed to promote faster healing, reduce the risk of infection, and improve patient outcomes.

There's an increasing emphasis on a multidisciplinary approach to diabetic foot ulcer management, involving specialists such as diabetologists, podiatrists, wound care experts, and nutritionists. This comprehensive care model aims to address all aspects of the condition, from blood sugar control to local wound care.

The demand for home healthcare services for diabetic foot ulcer treatment is growing, driven by patient preference for receiving care in the comfort of their homes. Home healthcare is also seen as a cost-effective alternative to hospital stays.

Telemedicine and remote monitoring are becoming increasingly important in managing diabetic foot ulcers, especially in rural or underserved areas. These technologies allow for regular monitoring of ulcers, timely intervention, and better patient education, improving overall patient management.

Governments and non-governmental organizations worldwide are initiating programs to raise awareness about diabetes and its complications, including diabetic foot ulcers. These initiatives often provide education, resources, and support to improve prevention, early detection, and management of diabetic foot ulcers.

Diabetic Foot Ulcers Market Segmentation

Market Breakup by Product Type
  • Biologics
  • Wound Care Dressings
Market Breakup by Type
  • Neuro-ischemic
  • Ischemic
  • Neuropathic
  • Others
Market Breakup by Route of Administration
  • Oral
  • Parenteral
  • Others
Market Breakup by End User
  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy
Market Breakup by Region
  • United States
  • EU-4 and the United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Japan
Diabetic Foot Ulcers Market Overview

North America, particularly the United States, shows a proactive approach to DFU management, marked by advanced healthcare facilities, a high standard of care, and significant investments in research and development. There is a strong emphasis on early detection and comprehensive treatment, including innovative wound care products and therapies. Public awareness campaigns and diabetes education programs also contribute to market dynamics.

Europe demonstrates a strong commitment to diabetes management and DFU treatment, supported by well-established healthcare systems and public health initiatives. The region sees a steady adoption of advanced wound care products, driven by a focus on reducing hospital stays and promoting cost-effective treatment options. European countries also have stringent regulations ensuring the quality and efficacy of medical products, influencing the DFU market landscape.

Japan is experiencing rapid growth in the DFU market, propelled by a rising diabetic population, increasing healthcare expenditure, and growing awareness of advanced wound care solutions. Countries like China, India, and Japan are investing in healthcare infrastructure improvement and diabetes management programs. However, there is considerable variation in access to advanced DFU treatments across different countries in the region.

Diabetic Foot Ulcers Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players.
  • ConvaTec, Inc.
  • Acelity L.P., Inc
  • 3M Healthcare
  • Coloplast Corp.
  • Smith & Nephew Plc
  • B Braun Melsungen AG
  • Medline Industries, Inc.
  • Organogenesis, Inc.
  • Molnlycke Health Care AB
  • Medtronics
  • Kerecis
  • Essity Aktiebolag AB
  • Tissue Regenix
  • Integra Lifesciences
  • Cardinal Health
We at Expert Market Research always strive to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.

*Please Note:* The report will take 7 business days to complete, after order confirmation.

Table of Contents

140 Pages
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Diabetic Foot Ulcers Overview
3.1 Guidelines and Stages
3.2 Pathophysiology
3.3 Screening and Diagnosis
3.4 Treatment Pathway
4 Patient Profile
4.1 Patient Profile Overview
4.2 Patient Psychology and Emotional Impact Factors
4.3 Risk Assessment and Treatment Success Rate
5 Diabetic Foot Ulcers Epidemiology Analysis – 7MM
5.1 7MM Epidemiology Scenario Overview (2017-2032)
5.2 United States Diabetic Foot Ulcers Epidemiology Forecast (2017-2032)
5.3 EU-4 and United Kingdom Diabetic Foot Ulcers Epidemiology Forecast (2017-2032)
5.3.1 Germany Diabetic Foot Ulcers Epidemiology Forecast (2017-2032)
5.3.2 France Diabetic Foot Ulcers Epidemiology Forecast (2017-2032)
5.3.3 Italy Diabetic Foot Ulcers Epidemiology Forecast (2017-2032)
5.3.4 Spain Diabetic Foot Ulcers Epidemiology Forecast (2017-2032)
5.3.5 United Kingdom Diabetic Foot Ulcers Epidemiology Forecast (2017-2032)
5.4 Japan Diabetic Foot Ulcers Epidemiology Forecast (2017-2032)
6 Diabetic Foot Ulcers Market Overview – 7MM
6.1 Diabetic Foot Ulcers Market Historical Value (2017-2023)
6.2 Diabetic Foot Ulcers Market Forecast Value (2024-2032)
7 Diabetic Foot Ulcers Market Landscape – 7MM
7.1 Diabetic Foot Ulcers Developers Landscape
7.1.1 Analysis by Year of Establishment
7.1.2 Analysis by Company Size
7.1.3 Analysis by Region
7.2 Diabetic Foot Ulcers Product Landscape
7.2.1 Analysis by Products
7.2.2 Analysis by Type
7.2.3 Analysis by Route of Administration
8 Diabetic Foot Ulcers Challenges and Unmet Needs
8.1 Treatment Pathway Challenges
8.2 Compliance and Drop-Out Analysis
8.3 Awareness and Prevention Gaps
9 Cost of Treatment
10 Diabetic Foot Ulcers Market Dynamics
10.1 Market Drivers and Constraints
10.2 SWOT Analysis
10.3 Porter’s Five Forces Model
10.4 Key Demand Indicators
10.5 Key Price Indicators
10.6 Industry Events, Initiatives, and Trends
10.7 Value Chain Analysis
11 Diabetic Foot Ulcers Market Segmentation – 7MM
11.1 Diabetic Foot Ulcers Market by Product Type
11.1.1 Market Overview
11.1.2 Biologics
11.1.3 Wound Care Dressings
11.2 Diabetic Foot Ulcers Market by Type
11.2.1 Market Overview
11.2.2 Neuro-ischemic
11.2.3 Ischemic
11.2.4 Neuropathic
11.2.5 Others
11.3 Diabetic Foot Ulcers Market by Route of Administration
11.3.1 Market Overview
11.3.2 Oral
11.3.3 Parenteral
11.3.4 Others
11.4 Diabetic Foot Ulcers Market by End User
11.4.1 Market Overview
11.4.2 Hospital Pharmacy
11.4.3 Online Pharmacy
11.4.4 Retail Pharmacy
11.5 Diabetic Foot Ulcers Market by Region
11.5.1 Market Overview
11.5.2 United States
11.5.3 EU-4 and the United Kingdom
11.5.3.1 Germany
11.5.3.2 France
11.5.3.3 Italy
11.5.3.4 Spain
11.5.3.5 United Kingdom
11.5.4 Japan
12 United States Diabetic Foot Ulcers Market
12.1 Diabetic Foot Ulcers Market Historical Value (2017-2023)
12.2 Diabetic Foot Ulcers Market Forecast Value (2024-2032)
12.3 Diabetic Foot Ulcers Market by Disease Type
12.4 Diabetic Foot Ulcers Market by Treatment Type
13 EU-4 and United Kingdom Diabetic Foot Ulcers Market
13.1 Diabetic Foot Ulcers Market Historical Value (2017-2023)
13.2 Diabetic Foot Ulcers Market Forecast Value (2024-2032)
13.3 Germany Diabetic Foot Ulcers Market Overview
13.3.1 Diabetic Foot Ulcers Market by Disease Type
13.3.2 Diabetic Foot Ulcers Market by Treatment Type
13.4 France Diabetic Foot Ulcers Market Overview
13.4.1 Diabetic Foot Ulcers Market by Disease Type
13.4.2 Diabetic Foot Ulcers Market by Treatment Type
13.5 Italy Diabetic Foot Ulcers Market Overview
13.5.1 Diabetic Foot Ulcers Market by Disease Type
13.5.2 Diabetic Foot Ulcers Market by Treatment Type
13.6 Spain Diabetic Foot Ulcers Market Overview
13.6.1 Diabetic Foot Ulcers Market by Disease Type
13.6.2 Diabetic Foot Ulcers Market by Treatment Type
13.7 United Kingdom Diabetic Foot Ulcers Market Overview
13.7.1 Diabetic Foot Ulcers Market by Disease Type
13.7.2 Diabetic Foot Ulcers Market by Treatment Type
14 Japan Diabetic Foot Ulcers Market
14.1 Diabetic Foot Ulcers Market Historical Value (2017-2023)
14.2 Diabetic Foot Ulcers Market Forecast Value (2024-2032)
14.3 Diabetic Foot Ulcers Market by Disease Type
14.4 Diabetic Foot Ulcers Market by Treatment Type
15 Patent Analysis
15.1 Analysis by Type of Patent
15.2 Analysis by Publication year
15.3 Analysis by Issuing Authority
15.4 Analysis by Patent Age
15.5 Analysis by CPC Analysis
15.6 Analysis by Patent Valuation
15.7 Analysis by Key Players
16 Grants Analysis
16.1 Analysis by year
16.2 Analysis by Amount Awarded
16.3 Analysis by Issuing Authority
16.4 Analysis by Grant Application
16.5 Analysis by Funding Institute
16.6 Analysis by NIH Departments
16.7 Analysis by Recipient Organization
17 Clinical Trials Analysis
17.1 Analysis by Trial Registration Year
17.2 Analysis by Trial Status
17.3 Analysis by Trial Phase
17.4 Analysis by Therapeutic Area
17.5 Analysis by Geography
18 Funding Analysis
18.1 Analysis by Funding Instances
18.2 Analysis by Type of Funding
18.3 Analysis by Funding Amount
18.4 Analysis by Leading Players
18.5 Analysis by Leading Investors
18.6 Analysis by Geography
19 Partnership and Collaborations Analysis
19.1 Analysis by Partnership Instances
19.2 Analysis by Type of Partnership
19.3 Analysis by Leading Players
19.4 Analysis by Geography
20 Supplier Landscape
20.1 ConvaTec, Inc.
20.1.1 Financial Analysis
20.1.2 Product Portfolio
20.1.3 Demographic Reach and Achievements
20.1.4 Mergers and Acquisition
20.1.5 Certifications
20.2 Acelity L.P., Inc
20.2.1 Financial Analysis
20.2.2 Product Portfolio
20.2.3 Demographic Reach and Achievements
20.2.4 Mergers and Acquisition
20.2.5 Certifications
20.3 3M Healthcare
20.3.1 Financial Analysis
20.3.2 Product Portfolio
20.3.3 Demographic Reach and Achievements
20.3.4 Mergers and Acquisition
20.3.5 Certifications
20.4 Coloplast Corp.
20.4.1 Financial Analysis
20.4.2 Product Portfolio
20.4.3 Demographic Reach and Achievements
20.4.4 Mergers and Acquisition
20.4.5 Certifications
20.5 Smith & Nephew Plc
20.5.1 Financial Analysis
20.5.2 Product Portfolio
20.5.3 Demographic Reach and Achievements
20.5.4 Mergers and Acquisition
20.5.5 Certifications
20.6 B Braun Melsungen AG
20.6.1 Financial Analysis
20.6.2 Product Portfolio
20.6.3 Demographic Reach and Achievements
20.6.4 Mergers and Acquisition
20.6.5 Certifications
20.7 Medline Industries, Inc.
20.7.1 Financial Analysis
20.7.2 Product Portfolio
20.7.3 Demographic Reach and Achievements
20.7.4 Mergers and Acquisition
20.7.5 Certifications
20.8 Organogenesis, Inc.
20.8.1 Financial Analysis
20.8.2 Product Portfolio
20.8.3 Demographic Reach and Achievements
20.8.4 Mergers and Acquisition
20.8.5 Certifications
20.9 Molnlycke Health Care AB
20.9.1 Financial Analysis
20.9.2 Product Portfolio
20.9.3 Demographic Reach and Achievements
20.9.4 Mergers and Acquisition
20.9.5 Certifications
20.10 Medtronics
20.10.1 Financial Analysis
20.10.2 Product Portfolio
20.10.3 Demographic Reach and Achievements
20.10.4 Mergers and Acquisition
20.10.5 Certifications
20.11 Kerecis
20.11.1 Financial Analysis
20.11.2 Product Portfolio
20.11.3 Demographic Reach and Achievements
20.11.4 Mergers and Acquisition
20.11.5 Certifications
20.12 Essity Aktiebolag AB
20.12.1 Financial Analysis
20.12.2 Product Portfolio
20.12.3 Demographic Reach and Achievements
20.12.4 Mergers and Acquisition
20.12.5 Certifications
20.13 Tissue Regenix
20.13.1 Financial Analysis
20.13.2 Product Portfolio
20.13.3 Demographic Reach and Achievements
20.13.4 Mergers and Acquisition
20.13.5 Certifications
20.14 Integra Lifesciences
20.14.1 Financial Analysis
20.14.2 Product Portfolio
20.14.3 Demographic Reach and Achievements
20.14.4 Mergers and Acquisition
20.14.5 Certifications
20.15 Cardinal Health
20.15.1 Financial Analysis
20.15.2 Product Portfolio
20.15.3 Demographic Reach and Achievements
20.15.4 Mergers and Acquisition
20.15.5 Certifications
21 Diabetic Foot Ulcers Market - Distribution Model (Additional Insight)
21.1 Overview
21.2 Potential Distributors
21.3 Key Parameters for Distribution Partner Assessment
22 Key Opinion Leaders (KOL) Insights (Additional Insight)
23 Company Competitiveness Analysis (Additional Insight)
23.1 Very Small Companies
23.2 Small Companies
23.3 Mid-Sized Companies
23.4 Large Companies
23.5 Very Large Companies
24 Payment Methods (Additional Insight)
24.1 Government Funded
24.2 Private Insurance
24.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us